POLYMED

Under Pressure

remains firmly bearish, with the stock extending its sequence of lower highs and lower lows and breaking below key support zones on strong selling pressure. The sharp decline accompanied by rising volumes signals distribution rather than a healthy pullback, keeping the trend negative. Unless the price manages to reclaim and sustain above the ₹1,500–1,550 area, further downside risk persists, with the ₹1,350–1,400 zone acting as the next crucial support.